Epratuzumab (LymphoCide)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 01:51, 26 November 2014 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Anti-CD22 antibody

Preliminary data

Acute lymphocytic leukemia

Advani et al. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia. link to original article

Retrieved from "https://hemonc.org/w/index.php?title=Epratuzumab_(LymphoCide)&oldid=6059"